| 630 | 4 | 113 |
| 下载次数 | 被引频次 | 阅读次数 |
近年来，肠道微生态逐渐成为医学研究的热门方向。多项研究证明，肠道微生态的平衡与肠道健康密切相关。随着结直肠癌(CRC)发病率和死亡率的增加，目前亟需更优的治疗手段，肠道微生态调控可能是其新方向。本文对中医和西医通过调控肠道微生态治疗CRC的现状及机制进行综述，揭示肠道微生态用于CRC治疗的潜力，旨在为从肠道微生态论治CRC提供理论依据。
Abstract：Intestinal microecology has been a hot direction of medical research recently. Many studies have proved that the balance of intestinal microecology is closely related to intestinal health. With the increase of incidence and mortality of colorectal cancer(CRC), better treatment is urgently needed. Intestinal microecology regulation may be a new potential therapeutic perspective for CRC. We reviewed the current situation and mechanism of traditional Chinese medicine and Western medicine in the treatment of CRC, and revealed the capacity of intestinal microecology for CRC treatment, in order to provide theoretical basis for treating CRC from intestinal microecology.
[1] Sung H,Ferlay J,Siegel R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] Hao W J,Hu C H,Huang Y B,et al.Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity[J].PloS one,2019,14(11):e0223738.
[3] Cameron A,Zaheer R,Adator E H,et al.Bacteriocin occurrence and activity in Escherichia coli isolated from bovines and wastewater[J].Toxins (Basel),2019,11(8):475.
[4] Wilson M R,Jiang Y D,Villalta P W,et al.The human gut bacterial genotoxin colibactin alkylates DNA[J].Science,2019,363(6428):eaar7785.
[5] Huttenhower C,Gevers D,Knight R,et al.Structure,function and diversity of the healthy human microbiome[J].Nature,2012,486(7402):207-214.
[6] Bultman S J.Emerging roles of the microbiome in cancer[J].Carcinogenesis,2014,35(2):249-255.
[7] Burns M B,Lynch J,Starr T K,et al.Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment[J].Genome Med,2015,7(1):55.
[8] Zhou C B,Fang J Y.The regulation of host cellular and gut microbial metabolism in the development and prevention of colorectal cancer[J].Crit Rev Microbiol,2018,44(4):436-454.
[9] Hill C,Guarner F,Reid G,et al.The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic[J].Nat Rev Gastroenterol Hepatol,2014,11(8):506-514.
[10] Raman M,Ambalam P,Kondepudi K K,et al.Potential of probiotics,prebiotics and synbiotics for management of colorectal cancer[J].Gut Microbes,2013,4(3):181-192.
[11] Rossi M.Nutraceuticals in colorectal cancer:a mechanistic approach[J].Eur J Pharmacol,2018,833:396-402.
[12] Kuugbee E D,Shang X Q,Gamallat Y,et al.Structural change in microbiota by a probiotic cocktail enhances the gut barrier and reduces cancer via TLR2 signaling in a rat model of colon cancer[J].Dig Dis Sci,2016,61(10):2908-2920.
[13] Hu J,Wang C,Ye L,et al.Anti-tumour immune effect of oral administration of Lactobacillus plantarum to CT26 tumour-bearing mice[J].J Biosci.2015;40(2):269-279.
[14] Pitsillides L,Pellino G,Tekkis P,et al.The effect of perioperative administration of probiotics on colorectal cancer surgery outcomes[J].Nutrients,2021,13(5):1451.
[15] 张艺璇，周秀彦，高湘旻.益生菌干预对结肠癌患者术后化疗并发症、预后及肠道菌群的影响[J].现代消化及介入诊疗，2020,25(6):768-771.
[16] 刘灏，刘永伟，彭仁群，等.益生菌对结肠癌化疗患者肠道菌群的影响分析[J].世界最新医学信息文摘，2019,19(45):56.
[17] 徐天翠.双歧杆菌三联活菌联合快速康复护理对大肠癌术后患者肠道菌群及CD4+ CD8+ CD4+/CD8+水平的影响[J].基层医学论坛，2022,26(26):124-126.
[18] De Almeida C V,de Camargo M R,Russo E,et al.Role of diet and gut microbiota on colorectal cancer immunomodulation[J].World J Gastroenterol,2019,25(2):151-162.
[19] 张园莲.抑制结直肠癌细胞HT-29增殖的益生菌筛选及其作用机理研究[D].昆明：昆明理工大学，2018.
[20] Solaymani-Mohammadi S,Lakhdari O,Minev I,et al.Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules[J].J Leukoc Biol,2016,99(3):475-482.
[21] 陈璐.基于减毒李斯特菌为载体的宫颈癌和结肠癌免疫疗法研究[D].杭州：浙江农林大学，2021.
[22] 宗帅.粒毛盘菌多糖抗肿瘤作用及其机制研究[D].合肥：合肥工业大学，2020.
[23] 崔曼曼.粪菌移植治疗湿热蕴结型结直肠癌模型小鼠的机制研究[D].南昌：江西中医药大学，2022.
[24] 郭礼.四君子汤联合化疗对大肠癌患者具核梭杆菌的影响及临床疗效观察[D].咸阳：陕西中医药大学，2021.
[25] 谢辉.基于肠道菌群与代谢组学的消癌解毒方抗结肠癌的机制研究[D].南京：南京中医药大学，2021.
[26] 桑天庆.消癌解毒Ⅱ号方抗结直肠癌作用机制研究[D].南京：南京中医药大学，2021.
[27] Jiang F,et al.Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-κB/IL6-STAT3 signaling pathway[J].Biomed Pharmacother,2020,125:109982.
[28] 吕骥.葛根芩连汤联合PD-1抑制剂通过重塑免疫微环境治疗结肠癌的机制研究[D].石家庄：河北医科大学，2020.
[29] Zhu L Q.Evodiamine inhibits high-fat diet-induced colitis-associated cancer in mice through regulating the gut microbiota[J].J Integr Med,2021,19(1):56-65.
[30] 孙一涵.石斛提取物毛兰素对人结直肠癌细胞的干预作用及机制研究[D].长春：长春中医药大学，2021.
[31] 施青青.霍山石斛多糖对结肠癌荷瘤小鼠的抑瘤作用研究[D].合肥：合肥工业大学，2021.
[32] 邢晗.人参皂苷Rb2调控TGF-β/smad信号通路影响结直肠癌细胞的研究[D].南京：南京中医药大学，2021.
[33] 郭泽尚.结直肠癌患者肠道菌群特定菌属变化及临床意义[D].长春：吉林大学，2021.
基本信息:
中图分类号:R735.34
引用信息:
[1]朱媛媛,周红光.肠道微生态调控在结直肠癌治疗中的研究进展[J].巴楚医学,2023,6(01):112-115.
基金信息:
国家自然科学基金项目(No:81973737)
2023-03-28
2023-03-28